Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Clarke

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|September 29, 2011
Funding grant proposals for scientific research: retrospective analysis of scores by members of grant review panelNicholas Graves, Adrian G Barnett, Philip Clarke
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 17, 2025
Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life ExpectancySymret Singh, Oliver Rivero-Arias, Philip Clarke
PLOS Mental Health|February 9, 2026
The 5Rs of Rugby: A qualitative evaluation of the development, delivery, and experience of a mental health literacy and social norms intervention with elite rugby union players in IrelandRobert C Dempsey, Deirdre Lyons, Philip Clarke
JAMA|August 18, 2016
Cost of Antihyperglycemic Medications in the United States--ReplyXinyang Hua, William H Herman, Philip Clarke
BMJ (Clinical Research Ed.)|October 19, 2002
Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63)Alastair Gray, Philip Clarke, Andrew Farmer, et al.
Health Economics|April 30, 2003
Missing... presumed at random: cost-analysis of incomplete dataAndrew Briggs, Taane Clark, Jane Wolstenholme, et al.
Health Economics|July 13, 2013
The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneityMaria Alva, Alastair Gray, Borislava Mihaylova, et al.
Health Economics|July 4, 2018
Accuracy of patient recall for self-reported doctor visits: Is shorter recall better?Kim Dalziel, Jinhu Li, Anthony Scott, et al.
Pharmacoeconomics|March 14, 2019
Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer PatientsMichelle Tew, Philip Clarke, Karin Thursky, et al.
Health and Quality of Life Outcomes|April 28, 2007
Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trialPaul Glasziou, Jan Alexander, Elaine Beller, et al.
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|September 29, 2011
Funding grant proposals for scientific research: retrospective analysis of scores by members of grant review panelNicholas Graves, Adrian G Barnett, Philip Clarke
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 17, 2025
Quantifying the Impact of Intervention on Health Outcomes: A Tool for Assessing Incremental Changes to Life ExpectancySymret Singh, Oliver Rivero-Arias, Philip Clarke
PLOS Mental Health|February 9, 2026
The 5Rs of Rugby: A qualitative evaluation of the development, delivery, and experience of a mental health literacy and social norms intervention with elite rugby union players in IrelandRobert C Dempsey, Deirdre Lyons, Philip Clarke
JAMA|August 18, 2016
Cost of Antihyperglycemic Medications in the United States--ReplyXinyang Hua, William H Herman, Philip Clarke
BMJ (Clinical Research Ed.)|October 19, 2002
Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63)Alastair Gray, Philip Clarke, Andrew Farmer, et al.
Health Economics|April 30, 2003
Missing... presumed at random: cost-analysis of incomplete dataAndrew Briggs, Taane Clark, Jane Wolstenholme, et al.
Health Economics|July 13, 2013
The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneityMaria Alva, Alastair Gray, Borislava Mihaylova, et al.
Health Economics|July 4, 2018
Accuracy of patient recall for self-reported doctor visits: Is shorter recall better?Kim Dalziel, Jinhu Li, Anthony Scott, et al.
Pharmacoeconomics|March 14, 2019
Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer PatientsMichelle Tew, Philip Clarke, Karin Thursky, et al.
Health and Quality of Life Outcomes|April 28, 2007
Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trialPaul Glasziou, Jan Alexander, Elaine Beller, et al.
Pageof 14